Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196

Watchlist Manager
Shanghai Fosun Pharmaceutical Group Co Ltd Logo
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Watchlist
Price: 27.26 CNY 0.74%
Market Cap: 69.7B CNY
Have any thoughts about
Shanghai Fosun Pharmaceutical Group Co Ltd?
Write Note

Shanghai Fosun Pharmaceutical Group Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Fosun Pharmaceutical Group Co Ltd
Gross Profit Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Gross Profit
ÂĄ18.8B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
15%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Gross Profit
ÂĄ9.1B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Gross Profit
ÂĄ4.8B
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
21%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Gross Profit
ÂĄ21.4B
CAGR 3-Years
-6%
CAGR 5-Years
5%
CAGR 10-Years
15%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Gross Profit
ÂĄ10.5B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
8%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Gross Profit
ÂĄ319.6m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Shanghai Fosun Pharmaceutical Group Co Ltd's Gross Profit?
Gross Profit
18.8B CNY

Based on the financial report for Jun 30, 2024, Shanghai Fosun Pharmaceutical Group Co Ltd's Gross Profit amounts to 18.8B CNY.

What is Shanghai Fosun Pharmaceutical Group Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
15%

Over the last year, the Gross Profit growth was -12%. The average annual Gross Profit growth rates for Shanghai Fosun Pharmaceutical Group Co Ltd have been 2% over the past three years , 3% over the past five years , and 15% over the past ten years .

Back to Top